This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Boston Scientific Inc (BSX)

NYSE: Health Care

Company Income Statement
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Sales 7.14B 7.25B 7.62B 7.81B
Cost of Sales 1.90B 2.06B 2.36B 2.30B
Gross Operating Profit 5.25B 5.19B 5.26B 5.51B
Selling, General, and Administrative Expenses 2.81B 2.69B 2.66B 2.76B
Research & Development 861.00M 886.00M 895.00M 939.00M
Operating Income before D & A (EBITDA) 1.57B 1.61B 1.70B 1.81B
Depreciation & Amortization 689.00M 683.00M 717.00M 816.00M
Interest Income 0.00 0.00 0.00 0.00
Other Income - Net -19.00M 22.00M 749.00M 234.00M
Special Income / Charges -663.00M -4.66B -725.00M -1.78B
Total Income Before Interest Expenses (EBIT) 101.00M -3.85B 923.00M -670.00M
Interest Expense 324.00M 261.00M 281.00M 393.00M
Pre-Tax Income -223.00M -4.11B 642.00M -1.06B
Income Taxes -102.00M -39.00M 201.00M 2.00M
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -121.00M -4.07B 441.00M -1.06B
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -121.00M -4.07B 441.00M -1.06B
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -121.00M -4.07B 441.00M -1.06B
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
643.00M 731.00M 1.26B 829.00M
Preferred Dividends
Net Income Available To Common -121.00M -4.07B 441.00M -1.06B
Basic EPS from Continuing Ops. -0.09 -2.89 0.29 -0.70
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -0.09 -2.89 0.29 -0.70
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -0.09 -2.89 0.29 -0.70
Basic Normalized Net Income/Share 0.48 0.52 0.83 0.54
EPS fr Continuing Ops. -0.09 -2.89 0.29 -0.70
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -0.09 -2.89 0.29 -0.70
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -0.09 -2.89 0.29 -0.70
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
0.48 0.52 0.83 0.54
Dividends Paid per Share 0.00 0.00 0.00 0.00
BSX News

BSX Boston Scientific Inc

Analysts Ratings for BSX

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 10 9 9 9
Moderate Buy 2 2 2 1
Hold 10 10 10 11
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET BSX ANALYST REPORT

Brokerage Partners

BSX Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs